ENVB
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Enveric Biosciences secured a new U.S. patent allowance for next-generation non-hallucinogenic mescaline derivatives in the EVM401 seriesSep 15, 2026
- Enveric Biosciences welcomes final FDA guidance on psychedelic drug developmentJul 28, 2026
- Enveric Biosciences reports positive preclinical phototoxicity results for lead neuroplastogen candidate EB-003May 19, 2026
- Enveric Biosciences expanded its IP portfolio with a new U.S. patent for psychiatric disorder treatmentsMay 13, 2026
- Enveric Biosciences highlighted positive preclinical results for EB-003 in PTSD modelsMay 5, 2026